Gilead granted Breakthrough Therapy Designation for Trodelvy

Gilead (GILD) announced that the FDA has granted Breakthrough Therapy Designation to Trodelvy for the treatment of adult patients with ...
The Breakthrough Therapy designation is supported by data from the randomized, open-label phase 2 SOLSTICE trial.
The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...
AIIMS researchers claim to have made significant progress in developing chimeric antigen receptor (CAR) T-cell therapy, ...
Scientists have discovered a key protein that helps cancer cells avoid detection by the immune system during a type of ...
Monroe Carell was a natural fit to offer the new therapy. Its multidisciplinary DMD Clinic, co-directed by Burnette, Soslow ...
CRISPR Gene editing therapy is used for the first time in living humans with amazing results.
New research has found that stimulant drugs and atomoxetine appear to be the best treatments for adults with ADHD - which is ...